SUSQUEHANNA INTERNATIONAL GROUP, LLP
Position in NUVB — Nuvation Bio Inc.
CIK 1446194
BALA CYNWYD, PA
Position in NUVB
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$616,099
+$473,976 QoQ
Shares Held
143,613
+805.4% QoQ
Ownership
0.041%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2021
19 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NUVB Over Time
Shares Held
Position Value (USD)
Derivatives in NUVB
reported options exposure · as of Mar 31, 2026CallValue
$716,001
CallShares
166,900
PutValue
$982,839
PutShares
229,100
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Mar 31, 2026SUSQUEHANNA INTERNATIONAL GROUP, LLP holds $1,176,415,994 across 355 Biotechnology names. NUVB ranks #216 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | CYTK |
Cytokinetics Inc
|
898,951 | $59,249,860 | |
| 2 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
174,268 | $57,660,053 | |
| 3 | AGIO |
Agios Pharmaceuticals, Inc.
|
1,344,953 | $45,499,759 | |
| 4 | ABVX |
Abivax S.A.
|
381,282 | $42,455,750 | |
| 5 | BBIO |
BridgeBio Pharma, Inc.
|
398,943 | $29,625,507 | |
| 6 | INSM |
INSMED Inc
|
173,630 | $28,391,977 | |
| 7 | CRSP |
CRISPR Therapeutics AG
|
593,406 | $28,228,323 | |
| 8 | TERN |
Terns Pharmaceuticals, Inc.
|
521,571 | $27,497,223 |
All Filings in NUVB
Export CSV
32 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $982,839 | 229,100 | Put | Other | 2026-05-15 | |
| 2026-03-31 | $716,001 | 166,900 | Call | Other | 2026-05-15 | |
| 2026-03-31 | $616,099 | 143,613 | Shares | Other | 2026-05-15 | |
| 2025-12-31 | $2,724,736 | 304,100 | Put | Other | 2026-02-17 | |
| 2025-12-31 | $142,123 | 15,862 | Shares | Other | 2026-02-17 | |
| 2025-12-31 | $6,657,280 | 743,000 | Call | Other | 2026-02-17 | |
| 2025-09-30 | $3,029,482 | 818,779 | Shares | Other | 2025-11-14 | |
| 2025-09-30 | $919,080 | 248,400 | Put | Other | 2025-11-14 | |
| 2025-09-30 | $52,170 | 14,100 | Call | Other | 2025-11-14 | |
| 2025-06-30 | $221,910 | 113,800 | Put | Other | 2025-08-14 | |
| 2025-06-30 | $771,301 | 395,539 | Shares | Other | 2025-08-14 | |
| 2025-06-30 | $2,364,570 | 1,212,600 | Call | Other | 2025-08-14 | |
| 2025-03-31 | $438,382 | 249,081 | Shares | Other | 2025-05-14 | |
| 2024-12-31 | $214,560 | 80,662 | Shares | Other | 2025-02-14 | |
| 2024-09-30 | $33,170 | 14,485 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $59,273 | 20,299 | Shares | Defined | 2024-08-15 | |
| 2023-12-31 | $232,665 | 154,083 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $19,057 | 14,222 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $82,985 | 46,103 | Shares | Defined | 2023-08-11 | |
| 2023-06-30 | $28,980 | 16,100 | Call | Defined | 2023-08-11 | |
| 2023-03-31 | $196,807 | 118,559 | Shares | Defined | 2023-05-16 | |
| 2022-12-31 | $48,716 | 25,373 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $22,624 | 10,100 | Put | Defined | 2022-11-14 | |
| 2022-09-30 | $169,503 | 75,671 | Shares | Defined | 2022-11-14 | |
| 2022-03-31 | $62,210 | 11,827 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $511,572 | 60,185 | Shares | Defined | 2022-04-05 | |
| 2021-12-31 | $124,100 | 14,600 | Put | Defined | 2022-04-05 | |
| 2021-09-30 | $224,832 | 22,619 | Shares | Defined | 2021-11-15 | |
| 2021-09-30 | $214,704 | 21,600 | Put | Defined | 2021-11-15 | |
| 2021-06-30 | $674,276 | 72,425 | Shares | Defined | 2021-08-11 | |
| 2021-06-30 | $784,833 | 84,300 | Put | Defined | 2021-08-11 | |
| 2021-03-31 | $346,292 | 33,138 | Shares | Defined | 2021-05-17 | |
| No filing history on record for this holder in this stock. | ||||||